Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Robinhood Markets, Inc. (HOOD) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Robinhood Markets, Inc.Trade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Robinhood Markets, Inc. vs Vir Biotechnology Inc. Common Stock — how do they compare? Robinhood Markets, Inc. trades at $98.11 (market cap $90.88B), while Vir Biotechnology Inc. Common Stock trades at $10.49 (market cap $1.76B). The key difference: Robinhood Markets, Inc. is far larger — about 51.6× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Robinhood Markets, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Robinhood Markets, Inc. for 75 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

HOODVIR
Market Cap
$90.88B$1.76B
Volume
23,337,8322,764,948
Sector
FinancialsHealth
52-Week High
$147.08$11.78
52-Week Low
$65.16$5.12
Typical Hold Time
75 Days0 Days
Enterprise Value
$97.42B$1.32B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Robinhood Markets, Inc.

Robinhood (HOOD) trades at $110.52, up 1.19% with neutral technical signals. The company shows strong fundamental improvement with 2025 revenue reaching $4.47B and net income of $1.88B, though valuation multiples remain elevated. Recent announcements include plans for 24/7 stock trading and expanded crypto offerings, driving positive media coverage. Analyst consensus remains bullish with a $138.60 price target, though the stock faces execution risks amid high expectations.

HOOD presents growth potential through product innovation and market expansion, but faces valuation concerns with a P/E of 44.73. Key risks include regulatory scrutiny of new offerings and competitive pressure in the brokerage sector. The upcoming Q3 2026 earnings on October 27 will be critical for validating the company's growth trajectory and justifying current premium multiples.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HOOD
61% Buy39% Sell
Avg holding period · 75 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Robinhood Markets, Inc.

Robinhood Markets, Inc. operates a financial services platform. The Company offers brokerage and cash management applications such as stocks, exchange-traded funds, options, and cryptocurrency. Robinhood Markets serves clients in the United States.

Read more on HOOD →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →